Comprehensive variant analysis and interpretation for rare disease

Ready-made and integrated NGS technology provides efficient rare disease evaluation

Current tools for rare variant analysis are fragmented, often involving several different pipelines that all require separate integration efforts and maintenance schedules. This disjointed framework prevents laboratories from scaling services effectively. Today, high-throughput labs need intuitive tools for variant calling, interpretation, and reporting in a comprehensive and seamless way.

The TruSight Software Suite consolidates all these tools at your fingertips. Simplify rare variant analysis and interpretation by calling, prioritizing, and reporting on variants from one software interface. The suite is designed for high-throughput labs using whole-genome and whole-exome sequencing to evaluate and report on variants associated with rare genetic disease.

Learn More about TruSight Software Suite
Rare Variant Analysis Made Easy

The TruSight Software Suite provides rapid turnaround for rare variant analysis with automated processing and joint variant calling. Powered by the speed and precision of the DRAGEN Platform,1 the suite performs comprehensive identification for key variant types, including:

  • Small variants
  • Copy number variants
  • Structural variants
  • Mitochondrial variants
  • Repeat expansions
  • Runs of homozygosity
  • Paralogs (eg, SMN1/SMN2)

By analyzing and visualizing multiple types at one time, you can easily view compound heterozygosity across variant categories.*

*TruSight Software Suite is compatible with both whole-genome sequencing and whole-exome sequencing samples. DRAGEN supports repeat expansion calling and SMN1/2 calling with whole-genome samples using PCR-Free methods.

Variant Filtering and Prioritization
Simplified Variant Annotation and Prioritization

Developed with input from leaders in genome interpretation of rare disease, the TruSight Software Suite annotates variants and genes from multiple public databases, such as ClinVar, OMIM, and gnomAD. Additional options to upload custom annotations and query aggregated cases with CaseLog help you leverage institutional knowledge and learn from previous findings. Multiple visualization options allow for quality control of different variants discovered.

Machine Learning To Enhance Analysis

TruSight Software Suite is equipped with multiple machine learning tools to decrease time, add context, and corroborate findings. Tools such as automated variant prioritization, automated literature search, and splice site characterization can augment your review of rare variants. With intuitive interpretation and reporting options, you can filter variants via gene lists, inheritance modes, custom annotations, complex logic, and more.

Simplified Variant Annotation and Prioritization

Integrated Rare Variant Analysis Workflow

Save time and avoid the fragmented, multi-tool workflows common in rare variant analysis. The TruSight Software Suite supports seamless integration into an Illumina sequencing workflow, from accession to final reports. Jumpstart an automated analysis and interpretation pipeline and manage a single proband or up to five relatives within a single interface.

Secure Infrastructure for Variant Analysis

Centralizing multiple interpretation tools allows for consistent, robust compliance. TruSight Software Suite is ISO-27001 and ISO-13485 certified and complies with HIPAA (third party audited) and the principles of the GDPR. We also offer options to integrate with your lab’s single sign-on policy and other security settings.

How to Use TruSight Software Suite

See how easy it is to use the TruSight Software Suite to visualize, triage, and interpret rare variants. This use case description guides you through the complete workflow using an example data set.

Read Use Case
Alt Name

Rare Variant Analysis and Interpretation

Scaling from Exome to Whole-Genome Sequencing with DRAGEN

The DRAGEN Bio-IT Platform enables GeneDx to scale to whole-genome analysis and identify variants with precision.

Read Article
Driving Standards and Best Practices in Clinical Sequencing

The Medical Genome Initiative consortium aims to expand access to high-quality clinical whole-genome sequencing for rare genetic diseases.

Read Article
Study Assesses Newborns with Suspected Rare Diseases

Can clinical whole-genome sequencing change care?

Read Article
Rare Disease Whole-Genome Sequencing

Whole-genome sequencing is the most comprehensive test for rare disease, with the potential for superior diagnostics and outcomes.

Learn More
Human Whole-Genome Sequencing

Previously a challenging application, human whole-genome sequencing is one of the simplest. It offers the most detailed view into our genetic code.

Learn More
Genetic and Rare Diseases

Our technology is helping to drive breakthroughs in genetic disease testing by facilitating early detection.

Learn More
Illumina DNA PCR-Free Prep
Illumina DNA PCR-Free Prep

High performance for sensitive applications such as human whole-genome sequencing.

Read Data Sheet
NovaSeq 6000 System
NovaSeq 6000 System

Get scalable throughput and flexibility for virtually any sequencing method, genome, and scale of project.

View System
DRAGEN Bio-IT Platform
DRAGEN Bio-IT Platform

Perform accurate, ultra-rapid secondary analysis of sequencing data.

View Product
Reference
  1. Miller NA, Farrow EG, Gibson M, et al. A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Med. 2015;7:100. doi: 10.1186/s13073-015-0221-8.